top of page


via nova therapeutics virus 1.png
via nova therapeutics virus 1.png

The Disease

  • Adenovirus is a common respiratory pathogen

  • Leading cause of pharyngitis (sore throat)

  • Our target is ocular infection by Adenovirus, which is the leading cause of conjunctivitis and epidemic keratoconjunctivitis (EKC)

The Need

  • Millions of cases of viral conjunctivitis occur annually throughout the developed world

  • No specific antivirals exist for its treatment

Our Inhibitor

  • Our inhibitor is a small molecule that disrupts adenovirus replication

  • It is active against adenovirus serotypes that cause sporadic viral conjunctivitis and EKC

Copy of via nova therapeutics adenovirus_edited.jpg
bottom of page